国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
15期
2260-2262
,共3页
转移性%前列腺癌%Gleason评分%免疫表达
轉移性%前列腺癌%Gleason評分%免疫錶達
전이성%전렬선암%Gleason평분%면역표체
Metastatic%Prostate cancer,Gleason score%Immunoexpression
目的 分析转移性与非转移性前列腺癌的Gleason评分及免疫表达的差异,为临床护理提供依据.方法 选取我院泌尿外科收治的经病理组织形态学确诊的无转移性前列腺癌患者45例和转移性前列腺癌患者36例,对其前列腺组织标本的Gleason评分及相关标记物PSA、PAP、P504S的免疫表达进行分析.结果 转移性前列腺癌患者的Gleason评分[(7.36±1.22)分]高于无转移性患者的评分[(6.55±1.12)分],经秩和检验,差异有统计学意义(P<0.05).≥71岁患者的免疫组化PSA、PAP含量≥(++)的阳性患者多于≤70岁的患者,差异有统计学意义(P<0.05).81例前列腺癌中,71例P504S呈阳性表达,占87.7%.结论 Gleason评分及PSA、PAP、P504S的免疫表达,能较准确地评估病情,促进护理随访和咨询质量.
目的 分析轉移性與非轉移性前列腺癌的Gleason評分及免疫錶達的差異,為臨床護理提供依據.方法 選取我院泌尿外科收治的經病理組織形態學確診的無轉移性前列腺癌患者45例和轉移性前列腺癌患者36例,對其前列腺組織標本的Gleason評分及相關標記物PSA、PAP、P504S的免疫錶達進行分析.結果 轉移性前列腺癌患者的Gleason評分[(7.36±1.22)分]高于無轉移性患者的評分[(6.55±1.12)分],經秩和檢驗,差異有統計學意義(P<0.05).≥71歲患者的免疫組化PSA、PAP含量≥(++)的暘性患者多于≤70歲的患者,差異有統計學意義(P<0.05).81例前列腺癌中,71例P504S呈暘性錶達,佔87.7%.結論 Gleason評分及PSA、PAP、P504S的免疫錶達,能較準確地評估病情,促進護理隨訪和咨詢質量.
목적 분석전이성여비전이성전렬선암적Gleason평분급면역표체적차이,위림상호리제공의거.방법 선취아원비뇨외과수치적경병리조직형태학학진적무전이성전렬선암환자45례화전이성전렬선암환자36례,대기전렬선조직표본적Gleason평분급상관표기물PSA、PAP、P504S적면역표체진행분석.결과 전이성전렬선암환자적Gleason평분[(7.36±1.22)분]고우무전이성환자적평분[(6.55±1.12)분],경질화검험,차이유통계학의의(P<0.05).≥71세환자적면역조화PSA、PAP함량≥(++)적양성환자다우≤70세적환자,차이유통계학의의(P<0.05).81례전렬선암중,71례P504S정양성표체,점87.7%.결론 Gleason평분급PSA、PAP、P504S적면역표체,능교준학지평고병정,촉진호리수방화자순질량.
Objective To provide support for clinical nursing by analyzing the Gleason scores and immunoexpressions in metastatic and non-metastatic prostate cancer.Methods 45 patients wih non-metastatic prostate cancer and 36 with metastatic prostate carcinoma diagnosed by pathological histology were chosen from the First Affiliated Hospital of Guangzhou Medical University.The Gleason scores and immunoexpressions of PSA,PAP,and P504S in prostatic tissues were analyzed.Results The Gleason score was higher in patients with metastatic prostate cancer thanin those with non-metastatic prostate cancer; and the rank-sum test showed there was a significant difference between the two groups (P<0.05).As compared with those aged ≤ 71,the positive immune expressions of PSA and PAP equal to or more than (++)were significantly increased in patients aged ≥ 71 (P<0.05).71 of the 81 patients were positive with P504S expression,accounting for 87.7 percent.Conclusions The Gleason score and immunoexpressions of PSA,PAP,and P504S can accurately assess the severity of prostate cancer and promote the quality of follow-up of nursing and consulting.